AZ’ lupus therapy fails to hit the mark

3rd September 2018 Uncategorised 0

AstraZeneca’s experimental drug anifrolumab has failed to hit targets in a late stage trial in patients with lupus.

More: AZ’ lupus therapy fails to hit the mark
Source: News